<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03866876</url>
  </required_header>
  <id_info>
    <org_study_id>PHE</org_study_id>
    <nct_id>NCT03866876</nct_id>
  </id_info>
  <brief_title>Eucapnic pH Compared With Arterial pH and Base Deficit</brief_title>
  <acronym>PHE</acronym>
  <official_title>Umbilical Cord Arterial Eucapnic pH Compared With Arterial pH and Base Deficit as Predictor of Severe Adverse Outcomes Among Term Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neonatal asphyxia per partum can be complicated by severe neurologic sequelae and can lead to
      neonatal death. Of the 0.2% of live births to cerebral palsy, 10 to 28% would be secondary to
      neonatal acidosis. Only metabolic acidosis plays a neurotoxic role, explaining the recent
      interest of Racinet et al. in the development of a new biochemical marker, more specific than
      pH or base deficit, of neonatal asphyxia per partum at risk of anoxo-ischemic encephalopathy.
      This eucapnic neonatal pH raises the hope of a biochemical marker of situations at risk of
      poor prognosis, with high diagnostic value, prognostic and forensic.

      Our hypothesis is that eucapnic pH is more efficient than cord blood arterial pH and base
      deficit in the prediction of adverse neurologic outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with at least one of these criteria including neonatal seizure, neonatal hypotonia requiring intensive care unit admission, neonatal encephalopathy, and/or neonatal death.</measure>
    <time_frame>Between 2000 and 2016</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">36435</enrollment>
  <condition>Neurologic Complication</condition>
  <arm_group>
    <arm_group_label>Hôpital Femme Mère Enfants births</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Eucapnic pH</intervention_name>
    <description>Collection of Biological marker (proposed by Racinet): eucapnic pH</description>
    <arm_group_label>Hôpital Femme Mère Enfants births</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All birth more than 37 weeks of amenorrhea at the maternity ward of the hospital
        Femme-Mère-Enfant from 1st of january 2000 to 31 december 2016
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All birth more than 37 weeks of amenorrhea at the maternity ward of the hospital
             Femme-Mère-Enfant

          -  from 1st of january 2000 to 31 december 2016

        Exclusion Criteria:

          -  Infants born out of the hospital and secondarily hospitalized in the hospital
             Femme-Mère-Enfant

          -  Children with congenital anomalies or without valid arterial and venous umbilical cord
             samples
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muriel DORET, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Muriel DORET, Prof.</last_name>
    <phone>4 27 85 51 70</phone>
    <phone_ext>33</phone_ext>
    <email>muriel.doret-dion@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muriel DORET, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Muriel DORET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>March 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2019</study_first_posted>
  <last_update_submitted>March 6, 2019</last_update_submitted>
  <last_update_submitted_qc>March 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

